Endovascular treatment for acute ischemic stroke in patients with tandem lesion in the anterior circulation: analysis from the METRICS study.


Journal

Journal of neurointerventional surgery
ISSN: 1759-8486
Titre abrégé: J Neurointerv Surg
Pays: England
ID NLM: 101517079

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 27 05 2022
accepted: 01 08 2022
medline: 31 8 2023
pubmed: 25 8 2022
entrez: 24 8 2022
Statut: ppublish

Résumé

Acute ischemic stroke (AIS) due to anterior circulation tandem lesion (TL) remains a technical and clinical challenge for endovascular treatment (EVT). Conflicting results from observational studies and missing evidence from the randomized trials led us to report a recent real-world multicenter clinical experience and evaluate possible predictors of good outcome after EVT. We analyzed all AIS patients with TL enrolled in the prospective national study METRICS (Mechanical Thrombectomy Quality Indicators Study in Czech Stroke Centers). A good 3-month clinical outcome was scored as 0-2 points in modified Rankin Scale (mRS), achieved recanalization using the Thrombolysis In Cerebral Infarction (TICI) scale and symptomatic intracerebral hemorrhage (sICH) according to the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST) criteria. Of 1178 patients enrolled in METRICS, 194 (19.2%) (59.8% males, mean age 68.7±11.5 years) were treated for TL. They did not differ in mRS 0-2 (48.7% vs 46.7%; p=0.616), mortality (17.3% vs 22.7%; p=0.103) and sICH (4.7% vs 5.1%; p=0.809) from those with single occlusion (SO). More TL patients with prior intravenous thrombolysis (IVT) reached TICI 3 (70.3% vs 50.8%; p=0.012) and mRS 0-2 (55.4% vs 34.4%; p=0.007) than those without IVT. No difference was found in the rate of sICH (6.2% vs 1.6%; p=0.276). Multivariate logistic regression analysis showed prior IVT as a predictor of mRS 0-2 after adjustment for potential confounders (OR 3.818, 95% CI 1.614 to 9.030, p=0.002). Patients with TL did not differ from those with SO in outcomes after EVT. TL patients with prior IVT had more complete recanalization and mRS 0-2 and IVT was found to be a predictor of good outcome after EVT.

Sections du résumé

BACKGROUND BACKGROUND
Acute ischemic stroke (AIS) due to anterior circulation tandem lesion (TL) remains a technical and clinical challenge for endovascular treatment (EVT). Conflicting results from observational studies and missing evidence from the randomized trials led us to report a recent real-world multicenter clinical experience and evaluate possible predictors of good outcome after EVT.
METHODS METHODS
We analyzed all AIS patients with TL enrolled in the prospective national study METRICS (Mechanical Thrombectomy Quality Indicators Study in Czech Stroke Centers). A good 3-month clinical outcome was scored as 0-2 points in modified Rankin Scale (mRS), achieved recanalization using the Thrombolysis In Cerebral Infarction (TICI) scale and symptomatic intracerebral hemorrhage (sICH) according to the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST) criteria.
RESULTS RESULTS
Of 1178 patients enrolled in METRICS, 194 (19.2%) (59.8% males, mean age 68.7±11.5 years) were treated for TL. They did not differ in mRS 0-2 (48.7% vs 46.7%; p=0.616), mortality (17.3% vs 22.7%; p=0.103) and sICH (4.7% vs 5.1%; p=0.809) from those with single occlusion (SO). More TL patients with prior intravenous thrombolysis (IVT) reached TICI 3 (70.3% vs 50.8%; p=0.012) and mRS 0-2 (55.4% vs 34.4%; p=0.007) than those without IVT. No difference was found in the rate of sICH (6.2% vs 1.6%; p=0.276). Multivariate logistic regression analysis showed prior IVT as a predictor of mRS 0-2 after adjustment for potential confounders (OR 3.818, 95% CI 1.614 to 9.030, p=0.002).
CONCLUSION CONCLUSIONS
Patients with TL did not differ from those with SO in outcomes after EVT. TL patients with prior IVT had more complete recanalization and mRS 0-2 and IVT was found to be a predictor of good outcome after EVT.

Identifiants

pubmed: 36002287
pii: jnis-2022-019176
doi: 10.1136/jnis-2022-019176
doi:

Substances chimiques

Fibrinolytic Agents 0

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e123-e128

Informations de copyright

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Daniel Sanak (D)

Department of Neurology, Palacký University Faculty of Medicine and University Hospital Olomouc, Olomouc, Czech Republic.

Martin Kocher (M)

Department of Radiology, Palacký University Faculty of Medicine and University Hospital Olomouc, Olomouc, Czech Republic martin.kocher@seznam.cz.

Jana Zapletalova (J)

Department of Biophysics and Statistics, Palacky University Olomouc, Olomouc, Czech Republic.

Filip Cihlar (F)

Department of Radiology, Masaryk Hospital in Usti nad Labem, Usti nad Labem, Czech Republic.

Daniel Czerny (D)

Department of Radiology, University Hospital Ostrava, Ostrava, Czech Republic.

David Cernik (D)

Department of Neurology, Krajska zdravotni as Masarykova nemocnice v Usti nad Labem oz, Usti nad Labem, Czech Republic.

Petr Duras (P)

Department of Radiology, University Hospital Plzen, Plzen, Czech Republic.

Jan Fiksa (J)

Department of Neurology, General University Hospital in Prague, Prague, Czech Republic.

Jakub Husty (J)

Department of Radiology and Nuclear Medicine, University Hospital Brno, Brno, Czech Republic.

Lubomir Jurak (L)

Department of Neurology, Regional Hospital Liberec, Liberec, Czech Republic.

Martin Kovar (M)

Department of Neurology, Na Homolce Hospital, Prague, Czech Republic.

Jiri Lacman (J)

Department of Radiology, Central Military Hospital Prague, Prague, Czech Republic.

Radek Padr (R)

Department of Radiology, University Hospital Motol Prague, Prague, Czech Republic.

Pavel Prochazka (P)

2nd Department of Internal Medicine, General University Hospital in Prague, Prague, Czech Republic.

Jan Raupach (J)

Department of Radiology, Charles University Faculty of Medicine and University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.

Martin Reiser (M)

Department of Neurology, Regional Hospital Ceske Budejovice, Ceske Budejovice, Czech Republic.

Vladimir Rohan (V)

Department of Neurology, Charles University Faculty of Medicine and University Hospital Plzen, Plzen, Czech Republic.

Martin Roubec (M)

Department of Neurology, University of Ostrava Faculty of Medicine and University Hospital Ostrava, Ostrava, Czech Republic.

Jindrich Sova (J)

Department of Radiology, Regional Hospital Ceske Budejovice, Ceske Budejovice, Czech Republic.

Miroslav Sercl (M)

Department of Radiology, Regional Hospital Liberec, Liberec, Czech Republic.

Miroslav Skorna (M)

Department of Neurology, Masaryk University Faculty of Medicine and University Hospital Brno, Brno, Czech Republic.

Libor Simunek (L)

Department of Neurology, Charles University Faculty of Medicine and University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.

Alena Snajdrova (A)

Department of Radiology, Na Homolce Hospital Prague, Prague, Czech Republic.

Martin Sramek (M)

Department of Neurology, Central Military Hospital Prague, Prague, Czech Republic.

Ales Tomek (A)

Department of Neurology, Motol University Hospital, Praha, Praha, Czech Republic.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH